These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 9259316)

  • 1. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo.
    Vayssière BM; Dupont S; Choquart A; Petit F; Garcia T; Marchandeau C; Gronemeyer H; Resche-Rigon M
    Mol Endocrinol; 1997 Aug; 11(9):1245-55. PubMed ID: 9259316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
    Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell type-dependent divergence of transactivation by glucocorticoid receptor ligand.
    Tanigawa K; Tanaka K; Nagase H; Miyake H; Kiniwa M; Ikizawa K
    Biol Pharm Bull; 2002 Dec; 25(12):1619-22. PubMed ID: 12499651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism.
    Vanden Berghe W; Francesconi E; De Bosscher K; Resche-Rigon M; Haegeman G
    Mol Pharmacol; 1999 Oct; 56(4):797-806. PubMed ID: 10496964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity.
    Belvisi MG; Wicks SL; Battram CH; Bottoms SE; Redford JE; Woodman P; Brown TJ; Webber SE; Foster ML
    J Immunol; 2001 Feb; 166(3):1975-82. PubMed ID: 11160246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transrepression and transactivation potencies of inhaled glucocorticoids.
    Dirks NL; Li S; Huth B; Hochhaus G; Yates CR; Meibohm B
    Pharmazie; 2008 Dec; 63(12):893-8. PubMed ID: 19177906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the dissociated steroid RU24858 does not exclude a role for inducible genes in the anti-inflammatory actions of glucocorticoids.
    Chivers JE; Gong W; King EM; Seybold J; Mak JC; Donnelly LE; Holden NS; Newton R
    Mol Pharmacol; 2006 Dec; 70(6):2084-95. PubMed ID: 16988013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial pharmacological effects of selective glucocorticoid receptor agonist in external eye diseases.
    Kato M; Hagiwara Y; Oda T; Imamura-Takai M; Aono H; Nakamura M
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):353-60. PubMed ID: 21574866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structural explanation of the effects of dissociated glucocorticoids on glucocorticoid receptor transactivation.
    Dezitter X; Fagart J; Taront S; Fay M; Masselot B; Hétuin D; Formstecher P; Rafestin-Oblin ME; Idziorek T
    Mol Pharmacol; 2014 Feb; 85(2):226-36. PubMed ID: 24225022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound a.
    Robertson S; Allie-Reid F; Vanden Berghe W; Visser K; Binder A; Africander D; Vismer M; De Bosscher K; Hapgood J; Haegeman G; Louw A
    J Biol Chem; 2010 Mar; 285(11):8061-75. PubMed ID: 20037160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of dissociated glucocorticoids RU24858 and RU24782 on TPA-induced skin tumor promotion biomarkers in SENCAR mice.
    Kowalczyk P; Junco JJ; Kowalczyk MC; Sosnowska R; Tolstykh O; Walaszek Z; Hanausek M; Slaga TJ
    Mol Carcinog; 2014 Jun; 53(6):488-97. PubMed ID: 23852815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of dissociative glucocorticoid activity.
    Bamberger CM; Schulte HM
    Eur J Clin Invest; 2000 Dec; 30 Suppl 3():6-9. PubMed ID: 11281371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory glucocorticoids: changing concepts.
    Newton R
    Eur J Pharmacol; 2014 Feb; 724():231-6. PubMed ID: 23747654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
    Maiyar AC; Phu PT; Huang AJ; Firestone GL
    Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
    Vandevyver S; Dejager L; Tuckermann J; Libert C
    Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human glucocorticoid receptor (GR) isoform {beta} differentially suppresses GR{alpha}-induced transactivation stimulated by synthetic glucocorticoids.
    Fruchter O; Kino T; Zoumakis E; Alesci S; De Martino M; Chrousos G; Hochberg Z
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3505-9. PubMed ID: 15755863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic and nongenomic effects of glucocorticoids.
    Stahn C; Buttgereit F
    Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of iNOS expression and NO production by anti-inflammatory steroids. Reversal by histone deacetylase inhibitors.
    Hämäläinen M; Lilja R; Kankaanranta H; Moilanen E
    Pulm Pharmacol Ther; 2008; 21(2):331-9. PubMed ID: 17913526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element.
    Uht RM; Anderson CM; Webb P; Kushner PJ
    Endocrinology; 1997 Jul; 138(7):2900-8. PubMed ID: 9202234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cells present an innate resistance to glucocorticoid treatment: implications for therapy of primary vasculitis.
    Koenen P; Barczyk K; Wolf M; Roth J; Viemann D
    Ann Rheum Dis; 2012 May; 71(5):729-36. PubMed ID: 22203687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.